MorphoSys Hits Refresh Button On Pipeline With Constellation Buy
Deal Worth $1.7bn Financed Through $2bn Partnership With Royalty
The German biotech had already hinted at possibly expanding through M&A, and Constellation was viewed as an attractive acquisition target.
